HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eija Jokitalo Selected Research

Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy)

11/2022Seipin localizes at endoplasmic-reticulum-mitochondria contact sites to control mitochondrial calcium import and metabolism in adipocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eija Jokitalo Research Topics

Disease

3Traumatic Brain Injuries (Traumatic Brain Injury)
06/2022 - 01/2018
2Lipodystrophy
11/2022 - 12/2016
2Anxiety Disorders (Anxiety Disorder)
01/2019 - 07/2018
2Virus Diseases (Viral Diseases)
11/2015 - 01/2007
1Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy)
11/2022
1Starvation
01/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021
1Poisoning
10/2019
1Hyperoxaluria (Oxaluria)
10/2019
1Gerodermia osteodysplastica
10/2019
1Necrosis
10/2019
1Tauopathies
11/2018
1Hepatocellular Carcinoma (Hepatoma)
11/2018
1Atherosclerotic Plaque (Atheroma)
01/2018
1Atherosclerosis
01/2018
1Parkinson Disease (Parkinson's Disease)
01/2017
1Neoplasms (Cancer)
03/2016
1Carcinoma (Carcinomatosis)
01/2016
1Infections
11/2015
1Wounds and Injuries (Trauma)
12/2014
1Cicatrix (Scar)
01/2012
1Prostatic Neoplasms (Prostate Cancer)
07/2007
1Neoplasm Metastasis (Metastasis)
03/2007
1Inflammation (Inflammations)
11/2006
1Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
11/2005
1Tobacco Use Disorder (Nicotine Dependence)
05/2005
1Lipidoses
11/2004
1Neuroblastoma
03/2003
1Sphingolipidoses (Sphingolipidosis)
02/2003

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
11/2022 - 03/2003
3salicylhydroxamic acid (SHAM)IBA
06/2022 - 01/2018
3CholesterolIBA
01/2018 - 02/2003
2Biological ProductsIBA
01/2019 - 12/2014
2LipidsIBA
01/2018 - 11/2005
1Adenosine Triphosphate (ATP)IBA
11/2022
1Amino AcidsFDA Link
01/2021
1Silicon Dioxide (Silica)FDA LinkGeneric
10/2019
1OxalatesIBA
10/2019
1Calcium OxalateIBA
10/2019
1Calcium PyrophosphateIBA
10/2019
1Pharmaceutical PreparationsIBA
10/2019
1Coat Protein Complex I (COPI)IBA
10/2019
1Ethylene Glycol (Monoethylene Glycol)IBA
10/2019
1Uric Acid (Urate)IBA
10/2019
1tau Proteins (tau Protein)IBA
11/2018
1CarbohydratesIBA
11/2018
1InflammasomesIBA
01/2018
1Lipoproteins (Lipoprotein)IBA
01/2018
1Dopamine (Intropin)FDA LinkGeneric
01/2017
1Nerve Growth Factors (Neurotrophins)IBA
01/2017
1Membrane Proteins (Integral Membrane Proteins)IBA
12/2016
1Antiviral Agents (Antivirals)IBA
03/2016
1Histone DemethylasesIBA
01/2016
1Viral ProteinsIBA
11/2015
1Actins (F Actin)IBA
01/2012
1prostatic acid phosphataseIBA
07/2007
1VaccinesIBA
07/2007
1Microfilament Proteins (Actin Binding Proteins)IBA
03/2007
1Peptides (Polypeptides)IBA
01/2007
1Complement System Proteins (Complement)IBA
11/2006
1Insulin ReceptorIBA
11/2005
1NicotineFDA Link
05/2005
1SterolsIBA
11/2004
1ThapsigarginIBA
03/2003
1StaurosporineIBA
03/2003

Therapy/Procedure

1Therapeutics
07/2018
1Immunotherapy
07/2007